IRON Reports $730M Cash, $63.5M Net Loss, Advances Phase 3 Bitopertin Enrollment, DISC-0974 ASCO Data, DISC-3405 PV/SCD Studies, $45.9M R&D Spend
Disc Medicine, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $71.97
+3.1% in 7d after detection
Post-detection moves
1h
—
1d
+1.6%
3d
+1.0%
7d
+3.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS